Friday, September 27, 2013 2:43:34 PM
Big volume =dr frost. Big money follows him and stock prices usually skyrocket
Recent COCP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:30:27 PM
- Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive • GlobeNewswire Inc. • 04/02/2026 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 12:30:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 12:30:22 PM
- Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs • GlobeNewswire Inc. • 03/31/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 08:30:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 12:30:32 PM
- First Subjects Dosed in Cocrystal Pharma’s Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment • GlobeNewswire Inc. • 03/09/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2026 01:30:54 PM
- Cocrystal Pharma’s First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026 • GlobeNewswire Inc. • 02/19/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 09:10:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:10:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:10:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:10:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2025 02:00:25 PM
- Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus • GlobeNewswire Inc. • 12/18/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 09:30:29 PM
- Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference • GlobeNewswire Inc. • 12/01/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 01:30:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 01:00:58 PM
- Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs • GlobeNewswire Inc. • 11/14/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2025 08:15:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 12:00:37 PM
- Cocrystal Pharma Insiders Purchase $1.03 Million in Private Placement Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 10/30/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2025 06:03:56 PM
